Victory Capital Management’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Victory Capital Management’s Portfolio NWBO Stock Details NWBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-101,003	Closed	-$16K	–	3812
2020 Q1	$16K	Buy	+101,003	New	+$16K	﹤0.01%	3205

Other funds holding NWBO

WJWM

Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return

MSAM

Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

LDB

Lee, Danner & Bass Nashville, Tennessee $1.73B AUM 36.69% 1-Year Est. Return

OCG

Opus Capital Group Cincinnati, Ohio $930M AUM 16.14% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

Victory Capital Management's NWBO Position: Q2 2020 in Review

Victory Capital Management sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q2 2020, closing a stake of 101,003 shares — an estimated $16K sold.

Victory Capital Management first reported a position in NWBO in Q1 2020 and held it in 1 quarter. The position peaked at $16K in Q1 2020. 5 funds tracked by Wall St. Rank hold NWBO as of Q2 2020.

Victory Capital Management reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q2 2020 after selling out during the quarter.
Victory Capital Management sold 101,003 Northwest Biotherapeutics, Inc. Common stock shares in Q2 2020, an estimated $16K.
Victory Capital Management first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q1 2020 and held it in 1 quarter.
Victory Capital Management's Northwest Biotherapeutics, Inc. Common stock position peaked at $16K in Q1 2020.
5 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.